Literature DB >> 2032926

Malignant hyperthermia in dogs.

T E Nelson1.   

Abstract

Malignant hyperthermia (MH) is an anesthetic agent-induced hypermetabolic state. Human beings and several other animal species, including dogs, have been described to be genetically predisposed to development of MH. The halothane-triggered MH syndrome was characterized in genetically predisposed dogs, and in vitro contracture sensitivity of biopsied gracilis muscle exposed to halothane and caffeine was quantitated. Within 1 hour of halothane administration, each MH-susceptible dog developed rapid increases in CO2 production and rectal temperature. Reversal of the hypermetabolic state was achieved when halothane was discontinued and dantrolene sodium was given i.v. Biopsied gracilis muscle from MH-susceptible dogs had abnormal in vitro contracture responses to halothane and caffeine. These findings were consistent with those observed for MH-susceptible human beings and pigs in which a loss in regulation of muscle cell Ca(+)+ is believed to be the primary etiologic event for induction of MH.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2032926

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  4 in total

Review 1.  To fire the train: a second malignant-hyperthermia gene.

Authors:  K Hogan
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

2.  Pharmacokinetic evaluation of oral dantrolene in the dog.

Authors:  J L Haraschak; V C Langston; R Wang; C Riggs; C Fellman; M K Ross; C Bulla; K Lunsford; A Mackin; T Archer
Journal:  J Vet Pharmacol Ther       Date:  2013-11-13       Impact factor: 1.786

3.  Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.

Authors:  Gennady Cherednichenko; Chris W Ward; Wei Feng; Elaine Cabrales; Luke Michaelson; Montserrat Samso; José R López; Paul D Allen; Isaac N Pessah
Journal:  Mol Pharmacol       Date:  2008-01-02       Impact factor: 4.436

4.  Gene transfer into canine myoblasts.

Authors:  S Braun; C Thioudellet; F Perraud; C Escriou; M C Claudepierre; H Homann; M Lusky; M Mehtali; R Bischoff; A Pavirani
Journal:  Cytotechnology       Date:  1999-07       Impact factor: 2.058

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.